Personalized Medicine Firm Newtopia Garners Investment from Bloom Burton | GenomeWeb

NEW YORK (GenomeWeb) – Investment bank Bloom Burton & Co. is proving funding to Ontario-based personalized health firm Newtopia, the company announced today.

Bloom Burton's support follows the announcement in October that the international insurance underwriter Argo Group US will invest in Newtopia and use the company's personalized medicine services across its US employee base to reduce corporate healthcare costs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.